Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically ...

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively ...

Positive feedback was based on Phase III AQUILA trial results, which showed a significant clinical benefit with Darzalex Faspro in patients with high-risk smoldering multiple myeloma.

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.